...
首页> 外文期刊>Protein Science: A Publication of the Protein Society >The amino terminus of PKA catalytic subunit--a site for introduction of posttranslational heterogeneities by deamidation: D-Asp2 and D-isoAsp2 containing isozymes.
【24h】

The amino terminus of PKA catalytic subunit--a site for introduction of posttranslational heterogeneities by deamidation: D-Asp2 and D-isoAsp2 containing isozymes.

机译:PKA催化亚基的氨基末端-通过脱酰胺作用引入翻译后异质性的位点:D-Asp2和D-isoAsp2含同工酶。

获取原文
获取原文并翻译 | 示例

摘要

Conserved deamidation of PKA catalytic subunit isozymes Calpha and Cbeta--more than 25% at Asn2 in vivo in both cases--has been shown to yield Asp2- and isoAsp2-containing isozymes (Jedrzejewski PT, Girod A, Tholey A, Konig N, Thullner S, Kinzel V, Bossemeyer D, 1998, Protein Sci 7:457-469). Isoaspartate formation in proteins in vivo is indicative of succinimide intermediates involved in both the initial deamidation reaction as well as the "repair" of isoAsp to Asp by the action of protein L-isoaspartyl (D-aspartyl) O-methyl transferase (PIMT). L-Succinimide is prone to racemization to D-succinimide, which may hydrolyze to D-isoAsp- and D-Asp-containing diastereomers with, respectively, no and poor substrate character for PIMT. To analyze native PKA catalytic subunit from cardiac muscle for these isomers the N-terminal tryptic peptides (T1) of the enzyme were analyzed following procedures refined specifically with a set of corresponding synthetic peptides. The methods combined high resolution high-performance liquid chromatography and a new mass spectrometric procedure for the discrimination between Asp- and isoAsp-residues in peptides (Lehmann et al., 2000). The results demonstrate the occurrence of D-isoAsp- and D-Asp-containing T1 fragments in addition to the L-isomers. The small amount of the L-isoAsp isomer, representing only part of the D-isoAsp isomer, and the relatively large amounts of the L-Asp and D-Asp isomers argues for an effective action of PIMT present in cardiac tissue.
机译:PKA催化亚基同功酶Calpha和Cbeta的保守脱酰胺作用(两种情况下体内Asn2均超过25%)已显示可产生含Asp2和isoAsp2的同功酶(Jedrzejewski PT,Girod A,Tholey A,Konig N, Thullner S,Kinzel V,Bossemeyer D,1998,Protein Sci 7:457-469)。体内蛋白质中的异十八碳酸盐形成表明,在蛋白质的L-异天冬氨酰(D-天冬氨酰)O-甲基转移酶(PIMT)的作用下,琥珀酰亚胺中间体参与了初始脱酰胺反应以及isoAsp与Asp的“修复”。 L-琥珀酰亚胺易于外消旋成D-琥珀酰亚胺,后者可能水解为D-isoAsp和D-Asp的非对映异构体,分别具有无PIMT和较差的底物特性。为了分析来自心肌的天然PKA催化亚基的这些异构体,按照专门用一组相应的合成肽精制的方法分析了酶的N末端胰蛋白酶肽(T1)。这些方法结合了高分辨率高效液相色谱法和新的质谱程序,可区分肽中的Asp和isoAsp残基(Lehmann等,2000)。结果证明除了L-异构体之外,还存在D-isoAsp-和含D-Asp的T1片段。少量的L-isoAsp异构体(仅代表D-isoAsp异构体的一部分)和相对大量的L-Asp和D-Asp异构体证明了心脏组织中PIMT的有效作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号